[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Xoma Royalty Corporation (XOMA)

Xoma Royalty Corporation (XOMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 526,722
  • Shares Outstanding, K 12,541
  • Annual Sales, $ 52,150 K
  • Annual Income, $ 31,710 K
  • EBIT $ 14 M
  • EBITDA $ 17 M
  • 60-Month Beta 0.90
  • Price/Sales 10.05
  • Price/Cash Flow 73.23
  • Price/Book 6.16

Options Overview Details

View History
  • Implied Volatility 17.10% (+0.91%)
  • Historical Volatility 40.61%
  • IV Percentile 5%
  • IV Rank 1.87%
  • IV High 172.07% on 12/12/25
  • IV Low 14.15% on 04/28/26
  • Expected Move (DTE 34) 1.30 (3.10%)
  • Put/Call Vol Ratio 14.50
  • Today's Volume 279
  • Volume Avg (30-Day) 761
  • Put/Call OI Ratio 1.58
  • Today's Open Interest 10,586
  • Open Int (30-Day) 6,721
  • Expected Range 40.70 to 43.30

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $0.19
  • Number of Estimates 3
  • High Estimate $0.50
  • Low Estimate $-0.16
  • Prior Year $0.06
  • Growth Rate Est. (year over year) +216.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
37.00 +13.51%
on 04/24/26
42.81 -1.89%
on 04/27/26
+2.59 (+6.57%)
since 04/14/26
3-Month
23.56 +78.31%
on 02/19/26
42.81 -1.89%
on 04/27/26
+17.99 (+74.93%)
since 02/13/26
52-Week
22.29 +88.43%
on 02/11/26
42.81 -1.89%
on 04/27/26
+15.26 (+57.07%)
since 05/14/25

Most Recent Stories

More News
Are XOMA, OGN, VRE Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

XOMA : 42.00 (+0.48%)
OGN : 13.36 (+0.15%)
VRE : 18.97 (+0.05%)
XOMA's Liquidation Pivot May Be Masking a Drying Royalty Stream

Barchart Research What to Expect from XOMA Earnings XOMA Generated May 11, 2026 Current Price $41.51 EPS Estimate $$0.19 Consensus Rating Moderate Buy Average Move 6.02% XOMA's Liquidation Pivot May Be...

XOMA : 42.00 (+0.48%)
Are SEM, XOMA, SLNO, KORE Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

XOMA : 42.00 (+0.48%)
KORE : 9.18 (+0.22%)
SEM : 16.46 (-0.06%)
SLNO : 52.99 (+0.08%)
SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--HLX, OGN, XOMA, and RMAX

NEW YORK , May 6, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars...

XOMA : 42.00 (+0.48%)
RMAX : 9.01 (-2.28%)
HLX : 10.14 (unch)
OGN : 13.36 (+0.15%)
Are XOMA, RMAX, KALV Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

XOMA : 42.00 (+0.48%)
KALV : 26.76 (-0.15%)
RMAX : 9.01 (-2.28%)
XOMA Royalty Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of XOMA Royalty Corporation - XOMA

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of XOMA Royalty ...

XOMA : 42.00 (+0.48%)
LGND : 218.98 (-1.01%)
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of XOMA Royalty Corporation

NEW YORK , April 27, 2026 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by XOMA Royalty Corporation (NASDAQ: XOMA) and its board of directors concerning the...

LGND : 218.98 (-1.01%)
XOMA : 42.00 (+0.48%)
Are OGN, RMAX, XOMA, REAX Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

XOMA : 42.00 (+0.48%)
RMAX : 9.01 (-2.28%)
OGN : 13.36 (+0.15%)
REAX : 1.7100 (-2.29%)
Shareholder Alert: Ademi LLP investigates whether XOMA Royalty Corporation is obtaining a Fair Price for Public Shareholders

MILWAUKEE , April 27, 2026 /PRNewswire/ -- Ademi LLP is investigating XOMA (NASDAQ: XOMA) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction...

XOMA : 42.00 (+0.48%)
XOMA Stock Alert: Halper Sadeh LLC is Investigating Whether XOMA Royalty Corporation is Obtaining a Fair Price for its Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transaction may contain terms that...

XOMA : 42.00 (+0.48%)

Business Summary

XOMA ROYALTY is a biotechnology royalty aggregator. The company acquires the potential future economics associated with pre-commercial therapeutic candidates which have been licensed to pharmaceutical or biotechnology companies. XOMA ROYALTY, formerly known as XOMA Corporation, is based in EMERYVILLE,...

See More

Key Turning Points

3rd Resistance Point 42.97
2nd Resistance Point 42.63
1st Resistance Point 42.32
Last Price 42.00
1st Support Level 41.67
2nd Support Level 41.33
3rd Support Level 41.02

See More

52-Week High 42.81
Last Price 42.00
Fibonacci 61.8% 34.97
Fibonacci 50% 32.55
Fibonacci 38.2% 30.13
52-Week Low 22.29

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.